Financial results - ENCORE ENTERPRISE PHARMACEUTICAL COMPANY SRL

Financial Summary - Encore Enterprise Pharmaceutical Company Srl
Unique identification code: 34958661
Registration number: J40/10791/2015
Nace: 2110
Sales - Ron
-
Net Profit - Ron
Employees
Open Account
Company Encore Enterprise Pharmaceutical Company Srl with Fiscal Code 34958661 recorded a turnover of 2024 of - , with a net profit of - and having an average number of employees of - . The company operates in the field of Fabricarea produselor farmaceutice de bază having the NACE code 2110.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Encore Enterprise Pharmaceutical Company Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 0 0 0 0 0 0 0 0 0 0
Total Income - EUR 0 0 0 0 0 0 0 0 0 0
Total Expenses - EUR 269 684 219 0 0 0 0 0 0 0
Gross Profit/Loss - EUR -269 -684 -219 0 0 0 0 0 0 0
Net Profit/Loss - EUR -269 -684 -219 0 0 0 0 0 0 0
Employees 0 0 0 0 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Encore Enterprise Pharmaceutical Company Srl

Rating financiar

Financial Rating -
ENCORE ENTERPRISE PHARMACEUTICAL...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Encore Enterprise Pharmaceutical...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Encore Enterprise Pharmaceutical...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Encore Enterprise Pharmaceutical...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Encore Enterprise Pharmaceutical Company Srl - CUI 34958661

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 691 0 0 0 0 0 0 0 0 0
Current Assets 225 223 0 0 0 0 0 0 0 0
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 0 0 0
Cash 225 223 0 0 0 0 0 0 0 0
Shareholders Funds -44 -728 -934 -917 -899 -882 -863 -865 -863 -858
Social Capital 225 223 219 215 211 207 202 203 202 201
Debts 960 950 934 917 899 882 863 865 863 858
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2110 - 2110"
CAEN Financial Year 2110
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 0 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 0 euro.
The company's Equity was valued at -858 euro, while total Liabilities amounted to 858 euro.

Risk Reports Prices

Reviews - Encore Enterprise Pharmaceutical Company Srl

Comments - Encore Enterprise Pharmaceutical Company Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.